August/September 2022 Tech Guide: Point-of-Care Assays and Analyzers
The August/September 2022 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
The August/September 2022 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
CLIA waiver clearance allows Binx to facilitate single visit testing for CT/NG in any of the more than 220,000 locations across the Unites States holding a CLIA certificate of waiver.
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
This month’s issue features point-of-care assays and analyzers from such companies as BioFire Diagnostics, EKF Diagnostics, and Roche Diagnostics.
Read MoreWith connectivity, point-of-care testing is on the front line when it comes to diagnosing and managing chronic diseases.
Read MoreRelaymed’s secure, cloud-based service will connect Siemens POC instruments to physician-office electronic health record systems, reducing the potential for errors and revenue loss.
Read MoreThe device is the first of the company’s Alinity family of diagnostic instruments to launch.
Read MoreThe company has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus.
Read MoreThis month’s issue features point-of-care assays and analyzers from such companies as Alere, Chembio, and Siemens Healthineers.
Read MoreUrinalysis instruments offer expanding feature sets designed to meet diverse testing requirements.
Read MoreThe assay delivers cardiac troponin I results in about 15 minutes from either whole blood or plasma samples.
Read MoreOne company takes a novel approach to point-of-care diagnostics that reimagines the immunoassay method as serial reactions in connected microfluidic chambers.
Read MoreGreater speed and accuracy mark POC trends.
Read MoreNew report of patent filings shows Abbott is top filer, followed by University of California.
Read MoreNova Biomedical will showcase its Stat Profile Prime blood gas analyzer at AACC booth 1226.
Read MoreBlood gas testing, central to managing critically ill hospital patients, is increasingly moving out of laboratories and closer to the patient’s bedside.
Read MoreThe StatStrip Glucose hospital meter system from Nova Biomedical is the first blood glucose monitoring system to receive FDA clearance for use throughout all hospital and professional healthcare settings, including intensive care settings, and the only FDA-cleared system for the detection and management of dysglycemia throughout all professional healthcare settings, including critical care.
Read MoreThe NC-stat DPNCheck from NeuroMetrix is a rapid, quantitative test designed to detect diabetic peripheral neuropathy early enough to allow physicians to select appropriate treatment.
Read More